ANGELICA HEDGLIN: Open Payments
NPI 1245934421 · KITTANNING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 135 payments from 39 companies in 2025. Trend: 2023 $1,416 · 2024 $3,415 · 2025 $2,732
Food & beverage: $2,472Education: $260
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 23 | $367 |
| Incyte Corporation | 11 | $297 |
| Janssen Biotech, Inc. | 10 | $188 |
| Astellas Pharma US Inc | 5 | $184 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Exelixis Inc. | 9 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Lilly USA, LLC | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
Products named: Enhertu, VERZENIO, Nubeqa, RYBREVANT, Padcev, MONJUVI, SCEMBLIX, INJECTAFER.
Industry payments across PA — which companies pay providers there.
